SEC Filings for Navidea Biopharmaceuticals Inc. (NAVB)

$ 0.907   0.1079 (+13.50%) Volume: 425.21k 8:00 PM EDT 19-Sep-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KReport of unscheduled material events or corporate changes.308/12/2019
10-QQuarterly report with a continuing view of a company's financial position3908/09/2019
8-KReport of unscheduled material events or corporate changes.908/08/2019
DEFA14AAdditional proxy soliciting materials - definitive506/28/2019
DEF 14AOfficial notification to shareholders of matters to be brought to a vote (Proxy)3806/28/2019
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%606/24/2019
SC 13GStatement of beneficial ownership of common stock by certain persons1106/24/2019
4Statement of changes in beneficial ownership of securities106/21/2019
8-KReport of unscheduled material events or corporate changes.8306/17/2019
424B5Prospectus filed under Rule 424(b)(5)4606/17/2019
424B5Prospectus filed under Rule 424(b)(5)4606/13/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities105/21/2019
4Statement of changes in beneficial ownership of securities105/17/2019
4Statement of changes in beneficial ownership of securities105/15/2019
<<
First
<
Prev
123456789101112131415